Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan.

Shiko KuribayashiFumihiko NakamuraSei-Ichiro MotegiKenichiro HaraHiroko HosakaAkiko SekiguchiMai IshikawaYukie EndoTomonari HaradaHidemi SorimachiMasaru ObokataMitsuo UchidaKoichi YamaguchiToshio Uraoka

Published in: Journal of gastroenterology (2024)

Patients with persistent reflux symptoms and those with absent contractility and GEFV grade III or IV should receive maintenance therapy with strong acid inhibition to prevent medication-refractory RE.

Keyphrases

systemic sclerosis
interstitial lung disease
adverse drug
healthcare
rheumatoid arthritis
sleep quality
physical activity
bone marrow